Delivery Order SPE2DB22D2206-SPE2DB25FHG87
Award Date
6/5/25
Potential Completion Date
6/6/25
Potential Value
$6.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,018.19, is for the supply of 4,567,448,573 units of 2 mg/2 mL naloxone syringes. The order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a...
This is a federal contract award issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,255.77 firm fixed-price delivery order is for the supply of 4,567,473,255 units of 2 mg/2 ml naloxone syringes. The award has an ultimate completion date of March 6, 2025 and was issued on March 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,213.48, is for the delivery of 4,567,754,528 units of 2 mg/2 mL naloxone syringes. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 2, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of 4,565,058,079 units of the naloxone 2 mg/2 ml syringe 2 ml to the U.S. Defense Department's Medical Supply Chain. The contract was awarded to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The firm-fixed-price delivery order has a ceiling value of $3,293.72 and an ultimate completion date of July 3, 2024. The contract is not set aside and was awarded directly by the Defense Logistics...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $3,091.99 firm-fixed-price contract is for the delivery of NALOXONE 0.4 MG/ML VIA, with a completion date of June 25, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award, valued at $1,537.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,562,321,657 units of Naloxone 2 mg/2 ml syringes, a critical medication used to treat opioid overdoses. This delivery order falls under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $2,527.15, is for the delivery of Naloxone 2 mg/2 ml syringes to an unspecified location. It is a firm fixed-price delivery order contract with the Defense Logistics Agency (DLA) Troop Support Medical under the agency's primary Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued up...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of 4,566,749,486 units of Naloxone HCL 4 mg Nasal Spray. The firm-fixed-price delivery order has a ceiling value of $2,086.45 and a completion date of December 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor with no set-aside designation indicated. The contract is an Indefinite Delivery Contract (IDC) valued at $999,999,999 through...
The federal contract award with ID SPE2DX15D2223|SPE2DX23F4LXL was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,598.43 firm fixed-price delivery order is for 4,562,321,660 units of the 2 mg/2 ml Naloxone syringe. This contract has no set-aside designation and represents a small portion of Amerisourcebergen's significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award is for the delivery of Naloxone 2 mg/2 ml syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,319.57, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is a firm fixed price delivery order with a period of performance through March 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract...